Yung, C. F., Le Bert, N., Kam, K. Q., Saffari, S. E., Tan, C. W., Mah, Y. Y., . . . (LKCMedicine), L. K. C. S. o. M. (2024). BNT162b2 vaccine induced variant-specific immunity, safety and risk of Omicron breakthrough infection in children aged 5 to 11 years: A cohort study.

Yung, Chee Fu, et al. BNT162b2 Vaccine Induced Variant-specific Immunity, Safety and Risk of Omicron Breakthrough Infection in Children Aged 5 to 11 Years: A Cohort Study. 2024.

Yung, Chee Fu, et al. BNT162b2 Vaccine Induced Variant-specific Immunity, Safety and Risk of Omicron Breakthrough Infection in Children Aged 5 to 11 Years: A Cohort Study. 2024.